Bolt BiotherapeuticsBOLT
13F holders, Q2 2026 (June 30)At the end of Q2 2026, 23 institutions reported holding Bolt Biotherapeutics Inc. (BOLT) in their 13F filings, down 1 from Q1 2026. 2 opened new positions and 3 sold out. The largest holders were Sofinnova Investments, Inc. ($530K), Renaissance Technologies ($380K) and Vivo Capital, LLC ($279K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Bolt Biotherapeutics Inc.
- CUSIP
- 097702203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $10K |
| Exits | 3 | $219K |
All 13F filers, Q1 2026 → Q2 2026: 72,035 shares bought and 88,760 shares sold, net −16,725 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 23 holders
| Sofinnova Investments, Inc. | 0.03% | No change | 137,721 | $530K |
| Renaissance Technologies | 0.00% | Add +27.7% | 98,625 | $380K |
| Vivo Capital, LLC | 0.03% | No change | 72,414 | $279K |
| Citadel Advisors | 0.00% | Add +462.9% | 56,903 | $219K |
| T3 Companies, LLC | 0.17% | No change | 38,000 | $146K |
| Board of Trustees of The Leland Stanford Junior University | 0.03% | No change | 35,977 | $139K |
| Pfizer Inc | 0.08% | No change | 31,305 | $134K |
| Lynx1 Capital Management LP | 0.01% | No change | 30,800 | $119K |
| Nano Cap New Millennium Growth Fund L P | 0.08% | No change | 27,500 | $106K |
| Geode Capital Management, LLC | 0.00% | Reduce -33.6% | 19,119 | $74K |
| Shay Capital LLC | 0.01% | Add +3.6% | 15,438 | $59K |
| BlackRock, Inc. | 0.00% | No change | 9,711 | $37K |
| Vanguard Capital Management LLC | 0.00% | No change | 7,060 | $27K |
| Nan Fung Group Holdings Ltd | 0.01% | Reduce -82.9% | 5,000 | $19K |
| Morgan Stanley | 0.00% | Reduce -1.4% | 3,145 | $12K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 3,095 | $12K |
| NewEdge Advisors, LLC | 0.00% | New | 2,530 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +56.5% | 1,710 | $7K |
| UBS Group AG | 0.00% | Reduce -67.6% | 255 | $982 |
| SBI Securities Co., Ltd. | 0.00% | Add +1200.0% | 130 | $501 |
| JPMorgan Chase & Co. | 0.00% | No change | 42 | $165 |
| Citigroup Inc. | 0.00% | New | 41 | $158 |
| Barclays PLC | 0.00% | No change | 6 | $23 |
"% of holder's portfolio" is BOLT's weight in each manager's 13F, not the share of Bolt Biotherapeutics Inc. the manager owns.